Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma, Clinical Cancer Research, June 2024, American Association for Cancer Research (AACR),
DOI: 10.1158/1078-0432.ccr-23-3552.
You can read the full text:

Read

Contributors

The following have contributed to this page